The Food and Drug Administration (FDA) informed that Granulex Aerosol Spray (trypsin, balsam peru, castor oil; Mylan) has been discontinued as of December 24, 2015. Mylan stated that it was due to market conditions.
Granulex Aerosol Spray is indicated for decubitus and varicose ulcers, and debridement. It works by relieving pain and promoting healing, debriding eschar and necrotic tissue physiologically; stimulating the vascular bed; improving epithelization by reducing premature epithelial desiccation and cornification; and reducing odor from malodorous necrotic wounds.
Both the 2oz and 4oz aerosols have been discontinued.
For more information visit (800) 796-9526 or visit FDA.gov.